Changes in Glycoprotein Expression after Platelet Activation: Differences between In Vitro and In Vivo Studies

Keywords

Platelet adhesion - platelet aggregation - GPIb - GPIIb-IIIa - receptor movement

• References

• 1 Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-50.
• 2 Nurden P. Bidirectional trafficking of membrane glycoproteins following platelet activation in suspension. Thromb Haemost 1997; 78: 1305-15.
• 3 Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res 1973; 05: 167-79.
• 4 White JG. Fine structural alterations induced in platelets by adenosine diphosphate. Blood 1968; 31: 604-22.
• 5 White JG. The morphology of platelet function. Meth Hematol 1983; 04: 1-25.
• 6 White JG. An overview of platelet structural physiology. Scanning Microscopy 1987; 01: 1677-700.
• 7 White JG. Functional significance of mobile receptors on human platelets. Arterioscler Thromb 1993; 13: 1236-43.
• 8 George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects and observations in patients 0during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78: 340-8.
• 9 Nomura S, Nagata H, Suzuki M, Kondo K, Ohga S, Kawakatsu T, Kido H, Fukuroi T, Yamaguchi K, Iwata K, Yanabu M, Soga T, Kokawa T, Yasunaga K. Microparticle generation during in vitro platelet activation by anti-CD9 murine monoclonal antibodies. Thromb Res 1991; 62: 429-39.
• 10 Dachary-Prigent J, Freyssinet JM, Pasquet JM, Carron JC, Nurden AT. Annexin-V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81: 2554-65.
• 11 Blockmans D, Deckmyn H, Vermylen J. Platelet activation. Blood Rev 1995; 09: 143-56.
• 12 Chow TW, Hellums JD, Moake JL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein-Ib initiates calcium influx associated with aggregation. Blood 1992; 80: 113-20.
• 13 Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI. Von Willebrand factor binding to platelet GPIb initiates signals for platelet activation. J Clin Invest 1991; 88: 1568-73.
• 14 Sakariassen KS, Bolhuis PA, Sixma JJ. Human platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 1979; 279: 636-8.
• 15 Stel HV, Sakariassen KS, de Groot PG, van Mourik JA, Sixma JJ. Von Willebrand factor in the vessel wall mediates platelet adherence. Blood 1985; 65: 85-90.
• 16 Weiss HJ, Turitto VT, Baumgartner HR. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood 1986; 67: 322-30.
• 17 Roth G. Developing relationships: arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoproteins. Blood 1991; 77: 5-19.
• 18 Weiss HJ, Turitto VT, Baumgartner HR. Further evidence that glycoprotein IIb-IIIa mediates platelet spreading on subendothelium. Thromb Haemost 1991; 65: 202-5.
• 19 Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, McIntire LV. Real-time analysis of sheardependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 1993; 81: 1263-76.
• 20 Abrams C, Shattil SJ. Immunological detection of activated platelets in clinical disorders. Thromb Haemost 1991; 65: 467-73.
• 21 Sims PJ, Ginsberg MH, Plow EF, Shattil SJ. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem 1991; 266: 7345-52.
• 22 Ginsberg MH, Frelinger AL, Lam SCT, Forsyth J, McMillan R, Plow EF, Shattil SJ. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformationspecific monoclonal antibodies. Blood 1990; 76: 2017-23.
• 23 Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101: 880-6.
• 24 Metzelaar MJ, Heijnen FG, Sixma JJ, Nieuwenhuis HK. Identification of a 33-Kd protein associated with the α-granule membrane (GMP-33) that is expressed on the surface of activated platelets. Blood 1992; 79: 372-9.
• 25 Escolar G, Leistikow E, White JG. The fate of the open canalicular system in surface and suspension-activated platelets. Blood 1989; 74: 1983-8.
• 26 Modderman PW, Admiraal LG, Sonnenberg A, Borne AEGKV. Glycoprotein V and glycoprotein Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992; 267: 364-9.
• 27 Li CQ, Dong JF, Lanza F, Sanan DA, Saetung G, Lopez JA. Expression of platelet glycoprotein (GP) V in heterologous cells and evidence for its association with GPIb alpha in forming a GPIb-IX-V complex on the cell surface. J Biol Chem 1995; 270: 16302-7.
• 28 Lopez JA, Leung B, Reynolds CC, Li CQ, Fox JEB. Efficient plasma membrane expression of a functional platelet glycoprotein Ib-IX complex requires the presence of its 3 subunits. J Biol Chem 1992; 267: 12851-9.
• 29 Clemetson KJ, Clemetson JM. Platelet GPIb-V-IX complex: structure, function, physiology, and pathology. Semin Thromb Hemost 1995; 21: 130-6.
• 30 White JG, Burris SM, Hasegawa D, Johnson M. Micropipette aspiration of human blood platelets: a defect in Bernard-Soulier’s syndrome. Blood 1984; 63: 1249-52.
• 31 Weiss HJ, Tschopp TB, Baumgartner HR. Impaired interaction of platelets with subendothelium in bleeding disorders. New Eng J Med 1975; 293: 619-23.
• 32 Hourdille P, Heilmann E, Combrie R, Winckler J, Clemetson KJ, Nurden AT. Thrombin induces a rapid redistribution of glycoprotein Ib-IX complexes within the membrane systems of activated human platelets. Blood 1990; 76: 1503-13.
• 33 Escolar G, Clemetson K, White JG. Persistence of mobile receptors on surfaceand suspension-activated platelets. J Lab Clin Med 1994; 123: 536-46.
• 34 Berger G, Masse JM, Cramer EM. Alpha-granule membrane mirrors the platelet plasma membrane and contains the glycoproteins Ib, IX, and V. Blood 1996; 87: 1385-95.
• 35 Youssefian T, Masse JM, Rendu F, Guichard J, Cramer EM. Platelet and megakaryocyte dense granules contain glycoproteins Ib and IIb-IIIa. Blood 1997; 89: 4047-57.
• 36 Nurden A, Cazes E, Bihour C, Humbert M, Combrie R, Paponneau A, Winckers J, Nurden P. Confirmation that GPIb-IX complexes have a reduced surface distribution on platelets activated by thrombin and TRAP-14mer peptide. Br J Haematol 1995; 90: 645-54.
• 37 van Zanten GH, Heijnen HFG, Hu Y, Schut-Hese KM, Slotweg PJ, de Groot PG, Sixma JJ, Nieuwland R. A fifty percent reduction of platelet surface glycoprotein Ib does not affect platelet adhesion under flow conditions. Blood 1998; 91: 2353-9.
• 38 White JG, Krumwiede MD, Cocking-Johnson D, Rao GHR, Escolar G. Retention of glycoprotein Ib/IX receptors on external surfaces of thrombin-activated platelets in suspension. Blood 1995; 86: 3468-78.
• 39 Michelson AD, Adelman B, Barnard MR, Carroll E, Handin RI. Platelet storage results in a redistribution of glycoprotein Ib molecules: evidence for a large intraplatelet pool of glycoprotein Ib. J Clin Invest 1988; 81: 1734-40.
• 40 George JN, Torres MM. Thrombin decreases von Willebrand factor binding to platelet glycoprotein Ib. Blood 1988; 71: 1253-9.
• 41 Michelson AD, Barnard MR. Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. Blood 1987; 70: 1673-8.
• 42 Cramer EM, Caen JP, Soria C, Berndt MC, Tenza D. Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation. Blood 1991; 77: 694-9.
• 43 Michelson AD, Ellis PA, Barnard MR, Matic GB, Viles AF, Kestin AS. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound. Blood 1991; 77: 770-9.
• 44 Wencel-Drake JD, Plow EF, Kunicki TJ, Woods JL, Keller DM, Ginsberg MH. Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses. Am J Pathol 1986; 324-34.
• 45 Suzuki H, Yamamoto N, Tanoue K, Yamazaki H. Glycoprotein Ib distribution on the surface of platelets in resting and activation sattes: an electron microscope study. Histochem J 1987; 19: 125-36.
• 46 Wencel-Drake JD. Platelet secretion and receptor cycling. Blood Cells 1991; 17: 486-95.
• 47 Purvis NB, Giorgio TD, Stelzer GT, Shults KE. Shear-induced platelet activation measured by flow cytometry. Ann N Y Acad Sci 1994; 714: 309-11.
• 48 Matzdorff AC, Kemkesmatthes B, Voss R, Pralle H. Comparison of betathromboglobulin, flow cytometry, and platelet aggregometry to study platelet activation. Haemostasis 1996; 26: 98-106.
• 49 Hourdille P, Gralnick HR, Heilman E, Derlon A, Ferrer A, Verzon G, Nurden AT. Von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation with thrombin. Blood 1992; 79: 2011-21.
• 50 White JG, Krumwiede M, Cocking-Johnson D, Escolar G. Influence of combined thrombin stimulation, surface activation, and receptor occupancy on organization of GPIb/IX receptors on human platelets. Br J Haematol 1994; 88: 137-48.
• 51 Lu H, Menashi S, Garcia I, Cramer EM, Li H, Tenza D, De Romeuf C, Soria J, Soria C. Reversibility of thrombin-induced decrease in platelet glycoprotein Ib function. Br J Haematol 1993; 85: 116-23.
• 52 Lu H, Soria C, Soria J, De Romeuf C, Perrot JY, Tenza D, Garcia I, Caen JP, Cramer EM. Reversible translocation of glycoprotein Ib in plasmintreated platelets: consequences for platelet function. Eur J Clin Invest 1993; 23: 785-93.
• 53 Michelson AD, Benoit SE, Kroll MH, Li JM, Rohrer MJ, Kestin AS, Barnard MR. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Blood 1994; 83: 3562-73.
• 54 Bode AP. Platelet activation may explain the storage lesion in platelet concentrates. Blood Cells 1990; 16: 109-26.
• 55 Rinder HM, Murphy M, Mitchell JG, Stocks J, Ault KA, Hillman RS. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991; 31: 409-14.
• 56 George JN. Changes in platelet membrane glycoproteins during blood bank storage. Blood Cells 1992; 18: 501-11.
• 57 Rinder HM, Snyder EL. Activation of platelet concentrate during preparation and storage. Blood Cells 1992; 18: 445-56.
• 58 George JN, Pickett EB, Heinz R. Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates. Transfusion 1988; 28: 123-6.
• 59 Metzelaar MJ, Korteweg J, Sixma JJ, Nieuwenhuis HK. Comparison of platelet membrane markers for the detection of platelet activation in vitro and during platelet storage and cardiopulmonary bypass surgery. J Lab Clin Med 1993; 121: 579-87.
• 60 Ribeiro A, Swann JC, Berndt MC. Alterations of the levels of glycoproteins Ib-IX and glycoproteins IIb-IIIa in platelets stored at 22 degrees C. Thromb Res 1992; 66: 619-27.
• 61 Bunescu A, Lundahl J, Soderstrom T, Lindahl T, Larsson A, Egberg N. Evaluation of platelet function by flow cytometric measurement of ligand binding. Platelets 1995; 06: 340-5.
• 62 Metcalfe P, Williamson LM, Reutelingsperger CPM, Swann I, Ouwehand WH, Goodall AH. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br J Haematol 1997; 98: 86-95.
• 63 Escolar G, White JG. Organization of von Willebrand factor on surfaceactivated platelets. Arterioscler Thromb 1993; 13: 1852-8.
• 64 Beumer S, Heijnen HFG, Ijsseldijk MJW, Orlando E, de Groot PG, Sixma JJ. Platelet adhesion to fibronectin in flow: the importance of von Willebrand factor and glycoprotein Ib. Blood 1995; 86: 3452-60.
• 65 White JG, Krumwiede MD, Johnson DK, Escolar G. Redistribution of GPIb/IX and GPIIb/IIIa during spreading of discoid platelets. Br J Haematol 1995; 90: 633-44.
• 66 Kieffer N, Guichard J, Breton-Gorius J. Dynamic redistribution of major platelet surface receptors after contact-induced platelet activation and spreading an immunoelectron microscopy study. Am J Pathol 1992; 140: 57-73.
• 67 White JG, Krumwiede MD, Cocking-Johnson D, Escolar G. Dynamic redistribution of glycoprotein Ib/IX on surface-activated platelets: a second look. Am J Pathol 1995; 147: 1057-67.
• 68 Tschoepe D, Roesen P, Schwippert B, Gries FA. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost 1993; 19: 122-8.
• 69 Tschope D, Rosen P, Schwippert B, Kehrel B, Schauseil S, Esser J, Gries FA. Platelet analysis using flowcytometric procedures. Platelets 1990; 01: 127-33.
• 70 Van Oeveren W. Leukocyte and platelet activation during extracorporeal circulation. Cell Mater 1994; 04: 187-95.
• 71 Gawaz MP, Mujais SK, Schmidt B, Gurland HJ. Platelet-leukocyte aggregation during hemodialysis. Kidney Int 1994; 46: 489-95.
• 72 Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 1978; 22: 347-53.
• 73 Escolar G, Monteagudo J, Castillo R, Cases A, Garrido M, Ordinas A. Ultrastructural immunolocalization and morphometric quantification of platelet membrane GPIb and GPIIb-IIIa in uremic patients. Prog Clin Biol Res 1988; 283: 197-201.
• 74 Gralnick HR, McKeown LP, Williams SB, Shafer B. Plasma and platelet von Willebrand factor defects in uremia. Am J Med 1989; 85: 806-10.
• 75 Zwaginga JJ, Ijsseldijk MJ, de Groot PG, Vos J, de Bos Kuil RL, Sixma JJ. Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma. Arterioscler Thromb 1991; 11: 733-44.
• 76 Sloand EM, Sloand JA, Prodouz K, Klein HG, Yu MW, Harvath L, Fricke W. Reduction of platelet glycoprotein Ib in uraemia. Br J Haematol 1991; 77: 375-81.
• 77 Sloand EM, Alyono D, Klein HG, Chang P, Yu M, Lightfoot FG, Kessler C. 1-deamino-8-d-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass. Am J Hematol 1994; 46: 199-207.
• 78 Kestin AS, Valeri CR, Khuri SF, Loscalzo J, Ellis PA, MacGregor H, Birjiniuk V, Ouimet H, Pasche B, Nelson MJ, Benoit SE, Rodino LJ, Barnard MR, Michelson AD. The platelet function defect of cardiopulmonary bypass. Blood 1993; 82: 107-17.
• 79 van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiov Surg 1990; 99: 788-97.
• 80 Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991; 75: 563-70.
• 81 Kondo C, Tanaka K, Takagi K, Shimono T, Shinpo H, Yada I, Yasa H, Kusagawa M, Akamatsu N, Tanoue K. Platelet disfunction during cardiopulamonary bypass surgery: with special reference to platelet membrane glycoproteins. ASAIO J 1993; 39: M550-3.
• 82 Nurden AT. Platelet membrane glycoproteins and their clinical aspects. Thromb Haemost 1987; 6-29.
• 83 Mohr R, Goor DA, Lusky A, Lavee J. Aprotinin prevents cardiopulmonary bypass induced platelet dysfunction: a scanning electron microscope study. Circulation 1992; 86: 405-9.
• 84 Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD. Effect of strenuous exercise on platelet activation state and reactivity. Circulation 1993; 88: 1502-11.
• 85 Escolar G, Lozano M, Diaz-Ricart M, Rao GHR, Ordinas A, White JG. Modifications in the accessibility of membrane glycoproteins, binding of specific ligands and coagulation factor V during the activation of platelets in blood emerging from bleeding time wounds. Am J Hematol 1999; 60: 260-7.
• 86 Konstantopoulos K, Chow TW, Turner NA, Hellums JD, Moake JL. Shear stress-induced binding of von Willebrand factor to platelets. Biorheology 1997; 34: 57-71.
• 87 Lozano M, Escolar G, White JG, Tassies D, Ordinas A, Diaz-Ricart M. Redistribution of membrane glycoproteins in platelets activated under flow conditions. Blood Coagul Fibrinol 1996; 07: 214-7.
• 88 Hagberg IA, Roald HE, Lyberg T. Platelet activation in flowing blood passing growing arterial thrombi. Arterioscler Thromb Vasc Biol 1997; 17: 1331-6.
• 89 Turitto VT, Weiss HJ, Baumgartner HR. Decreased platelet adhesion on vessel segments in von Willebrand’s disease: a defect in initial platelet attachment. J Lab Clin Med 1983; 102: 551-64.
• 90 Cramer EM, Savidge GF, Vainchenker W, Berndt MC, Pidard D, Caen JP, Masse JM, Breton-Gorius J. Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathologic platelets and megakaryocytes. Blood 1990; 75: 1220-7.
• 91 Suzuki H, Kaneko T, Sakamoto T, Nakagawa M, Miyamoto T, Yamada M, Tanoue K. Redistribution of alpha-granule membrane glycoprotein IIb/IIIa [integrin alpha (IIb) beta (3)] to the surface membrane of human platelets during the release reaction. J Electron Microsc 1994; 43: 282-9.
• 92 Woods VL, Wolff LE, Keller DM. Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not to other extracellular proteins. J Biol Chem 1986; 261: 15242-51.
• 93 Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307-15.
• 94 Frelinger AL, Cohen I, Plow EF, Smith MA, Roberts J, Lam SCT, Ginsberg MH. Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J Biol Chem 1990; 265: 6346-52.
• 95 Warkentin TE, Powling MJ, Hardisty RM. Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for the detection of platelet activation. Br J Haematol 1990; 76: 387-94.
• 96 Lindahl TL, Festin R, Larsson A. Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation. Thromb Haemost 1992; 68: 221-5.
• 97 Janes SL, Wilson DJ, Chronos N, Goodall AH. Evaluation of whole blood flow cytometric detection of platelet bound fibrinogen on normal subjects and patients with activated platelets. Thromb Haemost 1993; 70: 659-66.
• 98 Fijnheer R, Pietersz RNI, Dekorte D, Gouwerok CWN, Dekker WJA, Reesink HW, Roos D. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods. Transfusion 1990; 30: 634-8.
• 99 Rinder HM, Snyder EL, Bonan JL, Napychank PA, Malkus H, Smith BR. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release. Transfusion 1993; 33: 25-9.
• 100 Bock M, Gawaz MP, Dietzler A, Heim MU, Mempel W. Single-donor platelet concentrates: changes of surface glycoproteins during storage. Haemostasis 1994; 24: 230-5.
• 101 Bode AP, Orton SM, Frye MJ, Udis BJ. Vesiculation of platelets during in vitro aging. Blood 1991; 77: 887-95.
• 102 Loftus JC, Albrecht RM. Redistribution of the fibrinogen receptor of human platelets after surface activation. J Cell Biol 1984; 99: 822-9.
• 103 Leistikow EA, Barnhart MI, Escolar G, White JG. Receptor-ligand complexes are cleared to the open canalicular system of surface-activated platelets. Br J Haematol 1990; 74: 93-100.
• 104 White JG, Leistikow EL, Escolar G. Platelet membrane responses to surface and suspension activation. Blood Cells 1990; 16: 43-72.
• 105 White JG, Escolar G. Mobility of GPIIb-IIIa receptors within membranes of surface-and suspension-activated platelets does not depend on assembly and contraction of cytoplasmic actin. Eur J Cell Biol 1990; 52: 341-8.
• 106 White JG, Escolar G. Induction of receptor clustering, patching, and capping on surface-activated platelets. Lab Invest 1990; 63: 332-40.
• 107 White JG, Escolar G. Fibrinogen receptors do not undergo spontaneous redistribution on surface-activated platelets. Arteriosclerosis 1990; 10: 738-44.
• 108 White JG. Separate and combined interactions of fibrinogen-gold and latex with surface-activated platelets. Am J Pathol 1990; 137: 989-98.
• 109 Hernandez MR, Galan AM, Lozano M, Bozzo J, Cases A, Escolar G, Calls J, Ordinas A. Platelet-leukocyte activaton during hemodialysis detected with a monoclonal antibody to leukocyte integrin CD11b. Nephron 1998; 80: 197-203.
• 110 Di Minno G, Cerbone A, Usberti M, Cianciaruso B, Cortese A, Farace MJ, Martinez J, Murphy S. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. J Lab Clin Med 1986; 108: 246-52.
• 111 Escolar G, Cases A, Bastida E, Garrido M, López J, Revert L, Castillo R, Ordinas A. Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa. Blood 1990; 76: 1336-40.
• 112 Tsakiris DA, Haefeli WE, Linder L, Steiner B, Marbet GA. Platelet surface activation markers after DDAVP infusion in healthy subjects. Thromb Haemost 1995; 74: 991-992.
• 113 Mazer CD, Hornstein A, Freedman J. Platelet activation in warm and cold heart surgery. Ann Thorac Surg 1995; 59: 1481-6.
• 114 Bona RD, Sivjee KY, Hickey AD, Wallace DM, Wajcs SB. The efficacy and safety of oral anticoagulation in patients with cancer. Thromb Haemost 1995; 74: 1055-8.
• 115 Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet derived microparticles in humans. Blood 1990; 75: 128-38.
• 116 Wahba A, Black G, Koksch M, Rothe G, Preuner J, Schmitz G, Birnbaum DE. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass. Thromb Haemost 1996; 75: 844-8.
• 117 Janes SL, Kyle PM, Redman C, Goodall AH. Flow cytometric detection of activated platelets in pregnant women prior to the development of preeclampsia. Thromb Haemost 1995; 74: 1059-63.
• 118 Knight CJ, Panesar M, Wright C, Clarke D, Butowski PS, Patel D, Patrineli A, Fox K, Goodall AH. Altered platelet function detected by flow cytometry. Effects of coronary artery disease and age. Arterioscler Thromb Vasc Biol 1997; 17: 2044-53.
• 119 Scharf RE, Tomer A, Marzec UM, Teirsten PS, Ruggeri ZM, Harker LA. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb 1992; 12: 1475-87.
• 120 Gawaz M, Neumann FJ, Ott I, May A, Schomig A. Platelet activation and coronary stent implantation. Effect of antithrombotic therapy. Circulation 1996; 94: 279-85.
• 121 Gawaz M, Neumann FJ, Ott I, May A, Rudiger S, Schomig A. Changes in membrane glycoprotein of circulating platelets after coronary stent implantation. Heart 1996; 76: 166-72.
• 122 Fox JEB, Austin CD, Reynolds CC, Steffen PK. Evidence that agonistinduced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 1991; 266: 13289-95.
• 123 Lundahl TH, Lindahl TL, Fagerberg IH, Egberg N, Bunescu A, Larsson A. Activated platelets and impaired platelet function in intensive care patients analyzed by flow cytometry. Blood Coag Fibrinol 1996; 07: 218-20.
• 124 Gawaz M, Fateh-Moghadam S, Pilz G, Gurland HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 1995; 25: 843-51.
• 125 Coller BS, Kutok JL, Scudder LE, Galanakis DK, West SM, Rudomen GS, Springer KT. Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen. J Clin Invest 1993; 92: 2796-806.
• 126 Heynen HFG, Molero ML, de Groot PG, Nieuwenhuis HK, Sixma JJ. Absence of ligands bound to glycoprotein IIb-IIIa on the exposed surface of a thrombus may limit thrombus growth in flowing blood. J Clin Invest 1994; 94: 1098-112.
• 127 Tandon NN, Kralisz U, Jamieson GA. Identification of GPIV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 1989; 264: 7576-83.
• 128 Thibert V, Bellucci S, Edelman L, Tandon NN, Legrand C. Quantitation of platelet glycoprotein IV (CD36) in healthy subjects and in patients with essential thrombocythemia using an immunocapture assay. Thromb Haemost 1992; 68: 600-5.
• 129 Diaz-Ricart M, Tandon NN, Carretero M, Ordinas A, Bastida E, Jamieson GA. Platelet lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood. Blood 1993; 02: 491-6.
• 130 Diaz-Ricart M, Tandon NN, Gomez-Ortiz G, Carretero M, Escolar G, Ordinas A, Jamieson GA. Antibodies to CD36 (GPIV) inhibit platelet adhesion to subendothelial surfaces under flow conditions. Arterioscler Thromb Vasc Biol 1996; 16: 883-8.
• 131 Berger G, Caen JP, Berndt MC, Cramer EM. Ultrastructural demonstration of CD36 in the alpha-granule membrane of human platelets and megakaryocytes. Blood 1993; 82: 3034-44.
• 132 Michelson AD, Wencel-Drake JD, Kestin AS, Barnard MR. Platelet activation results in a redistribution of glycoprotein IV (CD36). Arterioscl Thromb 1994; 14: 1193-201.
• 133 Aiken ML, Ginsberg MH, Byersward V, Plow EF. Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression. Blood 1990; 76: 2501-9.
• 134 Thibert V, Bellucci S, Cristofari M, Gluckman E, Legrand C. Increased platelet CD36 constitutes a common marker in myeloproliferative disorders. Br J Haematol 1995; 91: 618-24.
• 135 McEver RP. Properties of GMP-140, and inducible granule membrane protein of platelets and endothelium. Blood Cells 1990; 16: 73-83.
• 136 McEver RP. Role of selectins in leukocyte adhesion to platelets and endothelium. Ann N Y Acad Sci 1994; 714: 185-9.
• 137 Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta (2)-integrin CD11b/CD18. Blood 1996; 88: 146-57.
• 138 Metzelaar MJ, Schuurman HJ, Heijnen HFG, Sixma JJ, Niewenhuis HK. Biochemical and immunohistochemical characteristics of CD62 and CD63 monoclonal antibodies: expression of GMP-140 and LIMP-CD63 (CD63 antigen) in human lymphoid tissues. Virchows Arch B – Cell Pathology Incl Mol Pathol 1991; 61: 269-77.
• 139 Israels SJ, Gerrard JM, Jacques YV, Mcnicol A, Cham B, Nishibori M, Bainton DF. Platelet dense granule membranes contain both granulophysin and P-selectin (GMP-140). Blood 1992; 80: 143-52.
• 140 Divers SG, Kannan K, Stewart RM, Betzing KW, Dempsey D, Fukuda M, Chervenak R, Holcombe RF. Quantitation of CD62, soluble CD62, and lysosome-associated membrane proteins 1 and 2 for evaluation of the quality of stored platelet concentrates. Transfusion 1995; 35: 292-7.
• 141 Kostelijk EH, Fijnheer R, Nieuwenhuis HK, Gouwerok CWN, Dekorte D. Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost 1996; 76: 1086-9.
• 142 Escolar G, Rao GH, Nieuwenhuis HK, White JG. Ultrastructural expression of P-selectin on surface activated platelets. Platelets 1996; 07: 297-301.
• 143 Reverter JC, Escolar G, Sanz C, Cases A, Villamor N, Nieuwenhuis HK, Lopez J, Ordinas A. Platelet activation during hemodialysis measured through exposure of P-selectin: analysis by flow cytometric and ultrastructural techniques. J Lab Clin Med 1994; 124: 79-85.
• 144 Cases A, Reverter JC, Escolar G, Sanz C, Lopez-Pedret J, Revert L, Ordinas A. Platelet activation on hemodialysis: influence of dialysis membranes. Kidney Int 1993; 43: S217-20.
• 145 Cases A, Reverter JC, Escolar G, Sanz C, Sorribes J, Ordinas A. In vivo evaluation of platelet activation by differents cellulosic membranes. Artif Organs 1997; 21: 330-4.
• 146 Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79: 1201-5.
• 147 Rabb H, Agosti SJ, Bittle PA, Fernandez M, Ramirez G, Tedder TF. Alterations in soluble and leukocyte surface L-selectin (CD 62L) in hemodialysis patients. J Am Soc Nephrol 1995; 06: 1445-50.
• 148 Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991; 75: 388-93.
• 149 Frijns CJM, Kappelle LJ, Vangijn J, Nieuwenhuis HK, Sixma JJ, Fijnheer R. Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 1997; 28: 2214-8.
• 150 Kirkpatrick UJ, Mossa M, Blann DA, McCollum CN. Repeated exercise induces release of soluble P-selectin in patients with intermittent claudication. Thromb Haemost 1997; 78: 1338-42.
• 151 Blann AD, Lip GYH. Hypothesis: Is soluble P-selectin a new marker of platelet activation?. Atherosclerosis 1997; 128: 135-8.
• 152 Santoso S, Zimmerman U, Neppert J, Mueller-Eckhardt C. Receptor patching and capping of platelet membranes induced by monoclonal antibodies. Blood 1986; 67: 343-9.
• 153 Santoso S, Kiefel V, Mueller-Eckhardt C. Redistribution of platelet glycoproteins induced by allo and autoantibodies. Thromb Haemost 1987; 58: 866-71.
• 154 White JG. Transfer of thorium particles from plasma to platelets and platelet granules. Am J Pathol 1968; 53: 567-75.
• 155 White JG, Clawson CC. Effects of large latex particle uptake of the surface connected canalicular system of blood platelets: a freeze-fracture and cytochemical study. Ultrastruct Pathol 1981; 02: 277-87.
• 156 Clawson CC, White JG. Platelet interaction with bacteria. V. Ultrastructure of congenital afibrinogenemic platelets. Am J Pathol 1980; 98: 197-211.
• 157 George JN. Platelet Immunoglobulin-G: its significance for the evaluation of thrombocytopenia and for understanding the origin of alpha-granule proteins. Blood 1990; 76: 859-70.
• 158 Morgenstern E, Ruf A, Patscheke H. Transport of anticlycoprotein IIb-IIIa antibodies into the alpha granules of unstimulated human blood platelets. Thromb Haemost 1992; 67: 121-5.
• 159 Behnke O. Surface membrane clearing of receptor ligand complexes in human blood platelets. J Cell Sci 1987; 87: 465-72.
• 160 Nurden P, Heilmann E, Paponneau A, Nurden A. Two-way trafficking of membrane glycoproteins on thrombin-activated human platelets. Semin Hematol 1994; 31: 240-50.
• 161 Michelson AD. Flow cytometric assessment of glycoprotein movements in platelets. Platelets 1997; 08: 105-15.
• 162 Estry DW, Mattson JC, Mahoney GJ, Oesterle JR. A Comparison of the fibrinogen receptor distribution on adherent platelets using both soluble fibrinogen and fibrinogen immobilized on gold beads. Eur J Cell Biol 1991; 54: 196-210.
• 163 Escolar G, Diaz-Ricart M, White JG. Talin does not associate exclusevely with α2bβ3 integrin in activated human platelets. J Lab Clin Med 1995; 125: 597-605.
• 164 Wencel-Drake JD, Boudignon-Proudhon C, Dieter MG, Criss AB, Parise LV. Internalization of bound fibrinogen modulates platelet aggregation. Blood 1996; 87: 602-12.
• 165 Peerschke EIB. Reversible and irreversible binding of fibrinogen to platelets. Platelets 1997; 08: 311-7.
• 166 Peerschke EIB. Bound fibrinogen distribution on stimulated platelets: examination by confocal scanning laser microscopy. Am J Pathol 1995; 147: 678-87.
• 167 White JG, Escolar G. Current concepts of platelet membrane response to surface activation. Platelets 1993; 04: 175-89.
• 168 Michelson AD. Thrombin-induced down-regulation of the platelet membrane glycoprotein Ib-IX complex. Semin Thromb Hemost 1992; 18: 18-27.
• 169 de Groot PG, Reinders JH, Sixma JJ. Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of their extracellular matrix towards platelets. J Cell Biol 1987; 104: 697-704.
• 170 Salatti JA, Fenton J, Anton P, Sakariassen KS. Alpha-Thrombin bound to extracellular endothelial matrix induces pronounced fibrin deposition and platelet thrombus growth in flowing non-anticoagulated human blood. Blood Coagul Fibrin 1994; 05: 561-6.
• 171 Badimon L, Badimon JJ, Lassila R, Heras M, Chesebro JH, Fuster V. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type-I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation. Blood 1991; 78: 423-34.
• 172 Chesebro JH, Zoldhelyi P, Badimon L, Fuster V. Role of thrombin in arterial thrombosis: implications for therapy. Thromb Haemost 1991; 66: 1-5.
• 173 Berndt MC, Gregory C, Chong BH, Zola H, Castaldi PA. Additional glycoprotein defects in Bernard-Soulier’s syndrome: confirmation of genetic basis by parental analysis. Blood 1983; 62: 800-7.
• 174 Fabris F, Casonato A, Randi ML, Luzzatto G, de Silvestro G, Ongaro G, Girolami A. The use of fluorescence flow cytometry in the characterization of Bernard-Soulier syndrome and Glanzmann’s thrombasthenia. Haematologica 1989; 74: 39-44.
• 175 McEver RP. GMP-140, a receptor that mediates interactions of leukocytes with activated platelets and endothelium. Trends Cardiovasc Med 1991; 01: 152-6.
• 176 Cerletti C, Rajtar G, Marchi E, de Gaetano G. Interaction between glycosaminoglycans, platelets, and leukocytes. Semin Thrombos Hemostas 1994; 20: 245-53.
• 177 Evangelista V, Manarini S, Rotondo S, Martelli N, Polischuk R, McGregor JL, de Gaetano G, Cerletti C. Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18. Blood 1996; 88: 4183-94.
• 178 Jamieson GA. Pathophysiology of platelet thrombin receptors. Thromb Haemost 1997; 78: 242-6.
• 179 Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996; 87: 4925-36.
• 180 Michelson AD. Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications. Blood Coagul Fibrinol 1994; 05: 121-31.
• 181 Zucker MB, Borrelli J. Reversible alterations in platelet morphology produced by anticoagulants and cold. Blood 1954; 09: 602-8.
• 182 White JG. Effects of ethylenediamine tetraacetic acid (EDTA) on platelet structure. Scand J Haematol 1968; 05: 241-54.
• 183 Gachet C, Hanau D, Spehner D, Brisson C, Garaud JC, Schmitt DA, Ohlmann P, Cazenave JP. Alpha IIb-beta3 integrin dissociation induced by EDTA results in morphological changes of the platelet surfaceconnected canalicular system with differential location of the 2 separate subunits. J Cell Biol 1993; 120: 1021-30.
• 184 Grant RA, Zucker MB, Mcpherson J. ADP-induced inhibition of von Willebrand factor-mediated platelet agglutination. Am J Physiol 1976; 230: 1406-10.
• 185 Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI. Plasmin effect on platelet GPIb-von Willebrand factor interactions. Blood 1985; 65: 32-40.
• 186 Pastakia KB, Terle D, Prodouz KN. Penicillin inhibits agonist-induced expression of platelet surface membrane glycoproteins. Ann N Y Acad Sci 1993; 667: 437-9.
• 187 Rao GHR, Peller JD, White JG. Influence of ionized calcium on thrombininduced downregulation of GPIb/IX receptors on human platelets. Thromb Res 1997; 85: 23-31.
• 188 White JG, Rao GHR. Thrombin-induced inhibition of platelet agglutination by von Willebrand factor (vWF): reversal by ionized calcium. Platelets 1996; 07: 321-8.
• 189 Winters KJ, Eisenberg PR, Jaffe AS, Santoro SA. Dependence of plasminmediated degradation of platelet adhesive receptors on temperature an Ca²⁺ . Blood 1990; 76: 1546-57.
• 190 Wicki AN, Clementson KJ. Structure and function of platelet membrane glycoproteins Ib and V: effect of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin. Eur J Biochem 1985; 153: 1-11.
• 191 LaRosa CA, Rohrer MJ, Benoit SE, Barnard MR, Michelson AD. Neutrophil cathepsin G modulates the platelet surface expression of the glycoprotein (GP) Ib-IX complex by proteolysis of the von Willebrand factor binding site on GPIb alpha and by a cytoskeletal-mediated redistribution of the remainder of the complex. Blood 1994; 84: 158-68.
• 192 Fox JEB. Shedding of adhesion receptors from the surface of activated platelets. Blood Coagul Fibrin 1994; 05: 291-304.
• 193 Pidard D, Renesto P, Berndt MC, Rabhi S, Clemetson KJ, Chignard M. Neutrophil proteinase cathepsin G is proteolytically active on the human platelet glycoprotein Ib-IX receptor: characterization of the cleavage sites within the glycoprotein Ib alpha subunit. Biochem J 1994; 303: 489-98.
• 194 Aziz KA, Cawley JC, Kamiguti AS, Zuzel M. Degradation of platelet glycoprotein Ib by elastase released from primed neutrophils. Br J Haematol 1995; 91: 46-54.
• 195 Wiedmer T, Shattil SJ, Cunningham M, Sims PJ. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of platelet factor Va receptor. Biochemistry 1990; 29: 623-32.
• 196 Fox JEB, Taylor RG, Taffarel M, Boyles JK, Goll DE. Evidence that activation of platelet calpain is induced as a consequence of binding of adhesive ligand to the integrin, glycoprotein IIb-IIIa. J Cell Biol 1993; 120: 1501-7.
• 197 Fujitani K, Kambayashi J, Ariyoshi H, Sakon M, Imajoh SOhmi, Nakamura T, Monden M. Calpain activation in shear-induced platelet aggregation. J Cell Biochem 1997; 66: 54-64.
• 198 Polak JM, Varndell IM. Immunolabelling for electron microscopy. Amsterdam, Elsevier; 1984
• 199 Griffiths G, Hoppeler H. Quantitation in immunocytochemistry: correlation of immunogold labeling to absolute number of membrane antigens. J Histochem Cytochem 1986; 34: 1389-98.
• 200 Hourdille P, Benabdallah S, Belloc P, Nurden AT. Distribution of glycoprotein IIb-IIIa complexes in the surface membranes of human platelets and megakaryocytes. Br J Haematol 1985; 59: 171-82.
• 201 Escolar G, White JG. Distribution of GPIb on and in resting platelets. Blood 1998; 92: 4874-7.
• 202 Gachet C, Hanau D, Spehner D, Brisson C, Ohlmann P, Schmitt DA, Cazenave JP. Alpha IIb-beta3 integrin dissociation induced by EDTA results in formation of birbeck granule like structures in human blood platelets. J Invest Dermatol 1992; 99: S27-9.
• 203 Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996; 88: 907-14.
• 204 Clemetson KJ, Polgar J, Clemetson JM. Snake venom C-type lectins as tools in platelet research. Platelets 1998; 09: 165-9.